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Abstract
Background: Assessment of synovitis in Rheumatoid Arthritis (RA) is a major issue for a proper treatment
administration; it has been proven that ultrasound (US) examination could be of valuable help and it is currently
being investigated as a possible outcome measure for the disease. It is, though, of greatest importance to
accurately establish the place of US scores among the already validated outcome measures, according to Outcome
Measures for Rheumatoid Arthritis in Clinical Trials (OMERACT) filter. The present study is designed to compare the
results of gray-scale ultrasound (GSUS) and Power Doppler ultrasound (PDUS) additive scores, separately calculated
for volar and dorsal aspects of the hand, with physical examination, patient’s evaluation of disease pain and global
activity on Visual Analogic Scale (VAS) and traditional scores for disease activity assessment (DAS28, CDAI, SDAI,
HAQ). The final aim is to prove the advantages of volar US evaluation in RA patients.
Methods: 42 RA patients have been clinically evaluated for pain and swelling of their hand joints, completed VAS
and HAQ questionnaires and underwent both volar and dorsal sonography of the hands during the same day. The
US examiner was blinded to clinical assessments and lab results. For each patient 20 joints were assessed by
sonography (radiocarpal, intercarpal, metacarpophalangeal (MCP) 2-5, proximal interphalangeal (PIP) 2-5). Carpal
joints were only evaluated from dorsal view, while MCPs and PIPs were evaluated both from dorsal and volar
aspect resulting a total of 36 distinct evaluations for each patient. GSUS synovial hypertrophy was assessed both by
quantitative measurement and semiquantitative scale (0-3 grades); Doppler signal (PDUS) was recorded on a
semiquantitative scale (0-3 grades). The semiquantitative grades for both GSUS and PDUS evaluation of each joint
were added and the sum was defined as the Echographic Score (ES) of each patient. Separately, we added the
semiquantitative grades for volar and dorsal side, resulting in Volar ES (VES) and Dorsal ES (DES) of each patient.
Results: We found ESs correlated with other activity scores: DAS28, CDAI, SDAI, HAQ. Correlations with clinical
indices as CDAI and SDAI were stronger for VES than for DES. US discovered more synovitis than clinical
examination.
Conclusion: VES is a suitable reflection of RA activity and volar US examination should accompany the dorsal one
both in clinical practice and in clinical trials.
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Background
T h er o l eo fU Si ne v a l u a t i n gt h es m a l lj o i n t so fR A
patients is still debatable in Rheumatology. It has been
heavily studied for its potential as an outcome measure,
but its standardization remains a problem. Both clinical
practice and clinical trials concerning RA are based
upon various composite indices for assessing disease
activity and responsiveness to treatment (DAS28, HAQ,
CDAI and SDAI). They have proven sensitivity to
change, validity and reliability; unfortunately they are
mainly based on subjective issues (like patient’sa p p r e -
ciation of pain). US was proven better than clinical
examination in detecting synovitis [1] and, given its
objective nature, several authors suggested it should be
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[2].
The concepts of intraarticular fluid and synovial
hypertrophy in GSUS are now clearly defined [3] and
also the standard position of the patient and transducer
for performing US [4]. Being an operator-dependent
technique, the reliability and reproducibility of GSUS
m a yb ei m p r o v e db ys e l e c t i n g the most appropriate
joint recess for the examination, another issue that is
still under debate [5].
The generally accepted method for synovial hypertro-
phy quantification is the semiquantitative scale [6,7],
with values between 0-3, where 0 = no intraarticular
changes, and 1-3 indicating mild, moderate, and large
synovial hypertrophy. The development of an US-based
global scoring system is one of the tasks of OMERACT
group [8]. A number of scoring systems have already
been developed [9-13], focusing mainly upon scanning a
limited number of joints to reduce the examination
time, and upon the sensitivity to change after remissive
treatment but there is limited data regarding the value
of volar vs. dorsal US examination of the same joint. In
a previous pilot study, we found higher correlations
between volar synovitis and clinical findings when com-
pared to the dorsal one [14]. The current study has
been conducted on a larger cohort, searching for corre-
lations between US synovitis score (volar and dorsal
separately) and the other parameters widely accepted as
reliable measures of disease activity. The final aim was
to identify the best scanning area (volar or dorsal) to be
used for global US scoring in RA.
Methods
42 RA patients (5 male, 37 female) who were admitted
to Sf. Maria Hospital starting from October 2008,
selected to have at least one painful or swollen joint
have been included in this study. All subjects fulfilled
ARA criteria for RA [15] and signed the written
informed consent for study participation before the
enrollment. The patients were informed about the pur-
poses of the study and about detailed study procedures.
With the exception of prolonged US examination, all
other procedures of this study are common at the
admittance of RA patients in Romania. This study was
approved by the medical ethical committee of the
“Carol Davila” University of Medicine and Pharmacy
Bucharest, Romania. Patients with major hand deformi-
ties were excluded from the group, because US images
could be altered from the misalignment of hand bones.
Mean (SD) age in our group was 55.7 (12.2) years, range
30-83; mean (SD) disease duration was 64.6 (77)
months, range 1-300. The patients were included
regardless of the treatment they were on at the enroll-
ment. All patients completed Visual Analogic Scale
(VAS) evaluation for their pain (VASP), for global activ-
ity of their disease (VAS global), and HAQ (Health
Assessment Questionnaires). VAS MD was recorded as
the clinician’s opinion regarding global RA activity of
the patients. A clinician, trained in RA assessments,
recorded for each patient then u m b e ro ft e n d e rj o i n t s
(TJC) and swollen joints (SJC). CDAI (clinical disease
assessment index) was calculated based upon TJC and
SJC, VAS global patient and VAS MD; DAS28 and
SDAI (Simplified Disease Activity Index) were then cal-
culated based upon lab results for ESR and CRP [16,17].
The main demographic characteristics of our patients
together with clinical and laboratory data in our group
are in Table 1.
Clinical examination
Clinical examination was performed for all patients by
the same physician trained in joints assessment - the
examination included all 28 joints from DAS28 [18].
TJC and SJC were recorded as follows: 1 if present and
0 if absent. Consequently, the same physician collected
the other variables: the patients’ VAS for global activity
and pain (0-10), HAQ filled by patients and made his
own appreciation of global disease activity on a VAS
MD questionnaire. ESR and CRP for all patients were
recorded at enrollment time.
Ultrasonography
US examination was performed later the same day, by a
sonographer trained in Musculoskeletal US for 8 years.
Table 1 Demographic, clinical and laboratory findings in
our patients N = 42
Range Mean (SD)
age 30.00 - 83.00 55.73 (12.23)
Disease duration (months) 3.00 - 300 64.64 (77.05)
DAS 28 3.46 - 8.30 6.15 (1.18)
VASP 4.00 -10.00 7.93 (1.72)
VAS global 4.00 -10.00 7.67 (1.64)
SJC 1.00 -18.00 7.61 (4.16)
TJC .00 - 24.00 13.04 (6.31)
VAS MD 2.00 - 93.00 10.69 (17.82)
HAQ .10 - 2.70 1.55 (.75)
ESR 4.00 - 130.00 50.02 (29.31)
CRP .00 - 209.30 30.65 (41.39)
CDAI 14.00 - 56.50 33.90 (11.13)
SDAI 15.50 - 264.30 64.23 (46.84)
VASP, Visual Analogic Scale for the patient’s pain; VAS global, patient’s global
evaluation of their disease activity; VAS MD, physician’s global evaluation
regarding patient’s disease activity; SJC, the number of swollen joints; TJC, the
number of tender joints; HAQ, Health assessment Questionnaire; ESR,
erithrocite sedimentation reaction, CRP, C reactive protein; CDAI, clinical
disease activity index; SDAI, simplified disease activity index
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MyLab 25, with a multifrequency linear 10-18 MHz
transducer. The scanning technique and the settings of
the machine were the same for all the patients and all
examinations were performed in a dark room by the
same physician, who was blinded to clinical evaluations.
Ultrasonography was performed on 10 joints at both
hands, 8 of them in both volar and dorsal aspect (MCPs
2-5, PIPs 2-5). Carpal joints (radiocarpal and intercarpal)
were only examined from the dorsal side, because of the
special position of carpal bones (we found no data
regarding volar incidence for carpal joints in the litera-
ture). MCP1 and PIP1 were excluded based upon the
rarity of synovitis in these locations in RA. For carpal
joints, scanning was performed in a longitudinal plane,
from dorsal side, over the surface of radius, lunate and
capitate bone [19]. For MCPs and PIPs, scanning was
performed longitudinally, over the joint space, first from
dorsal and then from volar side. No compression on the
transducer was applied. For Doppler signal evaluation,
standard Doppler settings of the machine were estab-
lished: Pulse Repetition Frequency (PRF) was adjusted to
maximize sensitivity - from 500 to 750 Hz, the highest
gain and high colour persistence without background
noise, low wall filter [12,20].
We measured the hypoechoic area between tendons
(extensors or flexors) and cortical bone, without differ-
entiating fluid and synovial hypertrophy. This hypoe-
c h o i ca r e ai n s i d et h ej o i n tw a sd e f i n e db e f o r ei n
literature as synovitis [21]. We performed dorsal mea-
surements perpendicularly to the bone, in the point of
the greatest thickness of hypoechoic area as follows: for
radiocarpal joint, on top of lunate bone; for intercarpal
joint, on top of capitate bone; for MCPs, at the level of
metacarpal neck, for PIPs, at the level of the first pha-
lanx [19].
GSUS synovial hypertrophy was assessed both by
quantitative measurement and semiquantitative scale (0-
3 grades); PDUS was recorded on a semiquantitative
scale (0-3 grades). The semiquantitative grades for each
joint were added and the sum was defined as the Echo-
graphic Score (ES) of each patient. Separately, we added
the semiquantitative grades for volar and dorsal side,
resulting in Volar ES (VES) and Dorsal ES (DES) of
each patient.
A dimension of 0.5 mm was considered the cutoff
limit for positive synovitis, and the number of joints
with synovitis above this value in each patient was
defined as Echographically Positive Joints (EPJ). As a
value > 3 mm in hand joints is perceived as large syno-
vitis [6], we counted it as 3 on semiquantitative scale;
for an accurate differentiation between grades 1 and 2
we made the transformations as follows: grade1 = syno-
vitis between 0.5-2 mm, grade 2 = synovitis between 2-3
mm. We used both scales of quantification because we
only found limited data in literature regarding semi-
quantitative scale on the volar side. For volar synovitis,
we measured the hypoechoic tissue between flexor ten-
don and cortical bone, perpendicularly to the bone, at
the point of its greatest thickness, and we quantified it
the same way as the dorsal one. Doppler signal was
semiquantitatively quantified, as described in the litera-
ture [22-24] on a 0-3 scale (0 = absence, 1 = mild, single
vessel signal, 2 = moderate, confluent vessels, 3 =
marked vessel signals in more than half of intraarticular
area).
Statistical analysis
We used SPSS 16.0 package; for quantitative parameters
we used mean, standard deviation and range. Correla-
tions between different variables were evaluated by 2-
sided exact Pearson’s correlation coefficients. Any value
of p < 0.05 was considered significant.
Results
We calculated global ES and separately VES respectively
DES (see Table 2). DES (mean, SD: 17.78, 6.71) was
found higher (t = 17.7, p < 0.01) than VES (11.69, 8,05).
We examined 16 finger joints (volar and dorsal, as
previously described) for each of the 42 patients
included in the study (a total of 672 joints for each
side). Radiocarpal and intercarpal joints have been
assessed from dorsal view only. The highest prevalence
of positive synovitis (>1 semiquantitatively) has been
found in carpal joints (91%). For the rest of the joints,
we found a variable prevalence of positive synovitis from
the highest (88.1%) in MCP2 volar side to the lowest
(35,7%) in PIP5 volar side.
We also counted for each side the number of EPJ
(joints that show at least grade 1 synovial hypertrophy
at US examination).We discovered a systematic higher
prevalence of GSUS positivity on the volar vs. dorsal
side (see Figure 1).
In the qualitative analysis, from the total number of
672 joints we found volar synovitis alone (regardless its
dimensions on semiquantitative scale) in 107 joints, dor-
sal alone in 88 joints and 477 joints were
Table 2 US parameters in our patients N = 42
Range Mean (SD)
SCORECO (ES) 7.00 - 64.00 29.47 (13.50)
VOLAR ES .00 - 30.00 11.69 (8.05)
DORSAL ES 6.00 - 34.00 17.78 (6.71)
EPJ 2.00 - 31.00 15.33 (7.76)
VOLAR EPJ .00 - 15.00 6.92 (4.21)
DORSAL EPJ 2.00 - 16.00 8.33 (4.20)
SCORECO, Echographic Score; EPJ, Number of Echographically Positive joints
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and dorsal side (see Figure 2).
In the quantitative analysis, when we compared the
dimensions of synovitis (on a 0 to 3 semiquantitative
scale), we found higher values for volar than dorsal
synovitis in 162 joints, higher dorsal than volar in 128
joints, and in 382 joints synovitis score was identical (p
< 0.05). The total number of joints with grade 3 synovi-
tis (the highest size) was found greater on volar side
(see Table 3).
Regarding PDUS, a variable prevalence in our patients
was found. Except for MCP2, with a mean Doppler
positivity prevalence of 20.23% (28.57% volar and 11.9%
dorsal), the mean prevalence for all other joints regard-
ing Doppler signal positivity was very low: 3.57% (5.27%
volar and 1.53% dorsal). The PD score resulted signifi-
cantly higher in volar than in dorsal aspect of joints (t =
4.8, p < 0,001)- see Figure 3.
ES significantly correlated with CDAI (Pearson’si n d e x
r = 0,628, p < 0,001) and SDAI (r = 0,403, p < 0,01).
VES correlated with CDAI (r = 0,470, p < 0.01) and
SDAI (r = 0.468, p < 0.01), and DES correlated with
CDAI but not with SDAI (r = 0.690, p < 0.01; r = 0,274,
p = 0,08). ES also correlated with DAS28 both on dorsal
and volar sides (r = 0,407, p < 0,01). ES correlated with
HAQ (p < 0.05), on both volar and dorsal sides. We did
not find any correlation between ESs and VAS for pain
and global activity, whilst a correlation between ES on
both sides and VAS MD was detected (p < 0.05).
The number of Echographically Positive Joints (EPJ)
significantly correlated with DAS28, TJC, SJC, CDAI,
SDAI and HAQ (for all of these p < 0,05). ES and both
VES and DES correlated well with TJC and SJC (Tables
4 and 5).
Discussion
Our data show the advantages of the volar US examina-
tion over the dorsal one in RA synovitis assessment - its
sensitivity qualifies for becoming a global outcome mea-
sure. Apart from that, the present study evaluated GSUS
and PDUS additive scores (ESs) in parallel with physical
examination, subjective evaluation of disease pain and
global activity and traditional tools for disease activity
evaluation in RA. US data have a higher significance
Figure 1 Prevalence of GSUS synovitis in volar versus dorsal aspect.
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disease activity, in particular because they need to be
measured regularly at 3 months interval, in order to bet-
ter control the disease [25]. In fact, we felt the need to
establish as accurately as possible a more objective mea-
sure based not only on clinician’sf e e l i n g ,b u ta l s oo n
their ability to correctly depict and quantify synovitis.
The role of US is to complement clinical examination
that sometimes can lead to false positive or false nega-
tive results [22]. As mentioned before, OMERACT is in
preparation for a global US score [8], combining best
parts of all scores described so far, in order to reach
maximal reliability, validity and responsiveness, inte-
grated together as OMERACT filter [26]. It is, though,
of highest importance to establish which joint recess
(dorsal or volar) is best correlated with accepted clinical
tools for RA activity quantification [5].
Our first pilot study on this matter (2005) stated that
volar synovitis is more correlated to clinical examination
than dorsal one [14]. Several studies have addressed
volar synovitis so far [11,27,28]. In 2004, Hoving et al
stated that in hand joints small amount of fluid is best
visualized from volar side with fingers in gentle flexion
[27]. In a recent scoring system, Backhaus found volar
synovitis present in 86% of affected joints, whilst dorsal
synovitis alone in only 14% [11]. Ostergaard and Szu-
dlarek found only 33% of patients having synovitis on
both volar and dorsal side; in the majority of their cases
synovitis was limited to volar- 43% or dorsal side - 27%
[28]. In our study, we did both qualitative and
Figure 2 Qualitative comparison in volar versus dorsal synovitis evaluation.
Table 3 Differences between volar and dorsal aspect on
semiquantitative scale (0-3) for synovial hypertrophy
Synovial hypertrophy
size
Difference Volar - Dorsal
(scale 0-3)
No. of
joints
Greater in volar +3 6
+2 51
+1 105
Simmilar in both
incidences
0 383
-1 88
-2 37
Greater in dorsal -3 2
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Page 5 of 9Figure 3 Prevalence of Doppler positive joints- volar versus dorsal.
Table 4 Correlations between ESs and measures of disease activity
SJC TJC HAQ CDAI SDAI ES VOLAR ES DOR ES
SJC Pearson Corr. 1 ,339* ,330* ,622** ,533** ,432** ,385* ,406**
Sig. (2-tailed) ,028 ,033 ,000 ,000 ,004 ,012 ,008
TJC Pearson Corr. ,339* 1 ,641** ,813** ,310* ,430** ,325* ,476**
Sig. (2-tailed) ,028 ,000 ,000 ,046 ,004 ,036 ,001
HAQ Pearson Corr. ,330* ,641** 1 ,608** ,516** ,321* ,291 ,296
Sig. (2-tailed) ,033 ,000 ,000 ,000 ,038 ,061 ,057
CDAI Pearson Corr. ,622** ,813** ,608** 1 ,574** ,591** ,471** ,625**
Sig. (2-tailed) ,000 ,000 ,000 ,000 ,000 ,002 ,000
SDAI Pearson Corr. ,533** ,310* ,516** ,574** 1 ,351* ,379* ,251
Sig. (2-tailed) ,000 ,046 ,000 ,000 ,023 ,013 ,109
ES Pearson Corr. ,432** ,430** ,321* ,591** ,351* 1 ,929** ,897**
Sig. (2-tailed) ,004 ,004 ,038 ,000 ,023 ,000 ,000
VOLAR ES Pearson Corr. ,385* ,325* ,291 ,471** ,379* ,929** 1 ,670**
Sig. (2-tailed) ,012 ,036 ,061 ,002 ,013 ,000 ,000
DOR ES Pearson Corr. ,406** ,476** ,296 ,625** ,251 ,897** ,670** 1
Sig. (2-tailed) ,008 ,001 ,057 ,000 ,109 ,000 ,000
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analysis we found echographically identical synovitis
(positive or negative) on volar and dorsal side in 477
joints, with volar alone positivity higher. In the quantita-
tive analysis, when we compared the dimensions of
synovitis (0-3 semiquantitative scale), we found higher
values for volar than dorsal synovitis in 162 joints,
higher dorsal than volar in 128 joints, and in 382 joints
synovitis score was identical (p < 0.05). No other statis-
tical correlations between the two sides, joint by joint,
were found in the literature.
According to literature, volar synovitis is always found
on the proximal area of MCP and PIP joints [28]. We
u s e dt h es a m em e t h o dp r e v i o u s l yd e s c r i b e d[ 2 8 ]f o r
depicting volar synovitis: with the transducer placed
longitudinally, without compression, on the median line
of the joint, measuring the hypoechoic area between
flexor tendon and bone contour, proximal to volar plate.
As we found no published correlations between quanti-
tative and semiquantitative scale for volar synovitis, we
used our own scale: 0.5-2 mm = grade 1, 2-3 mm =
grade2, >3 mm = grade3 (same correspondence as for
dorsal synovitis evaluation).
Our results are consistent with literature data as we
found a higher percentage of positivity on GSUS but
also on PDUS on the volar side. As the study involves
calculating ES as the sum of semiquantitative values of
GSUS, we also calculated ES for volar and dorsal side,
separately. We found all ESs significantly correlated
with standard measures of disease activity (DAS28,
CDAI, SDAI, SJC, TJC, HAQ). We found the differences
in synovitis depicting between the two aspects of joints
statistically significant, especially regarding PDUS (p <
0.001). We found no previous data in literature regard-
ing comparison of PDUS on volar vs dorsal sides.
Data in recent literature emphasize the necessity of
establishing “target joints”, meaning joints most fre-
quently involved in RA for scoring global synovitis, in
order to shorten the time of US examination [11-13].
Wrist being the most affected joint in RA (mean of 67%
of cases), it has been selected as a” target joint” in clini-
cal trials, being used in most of the scores available to
date. Except for the wrist, different scores used different
“target joints": MCPs 2, 3, 5, PIPs 2,3 and MTPs. We
found positivity prevalence of MCP4 comparable to
MCP3 or 5, probably because of volar synovitis contri-
bution (in most of the previous studies, MCP4 was not
considered “target joint”). - see Figure 1
As a personal observation, we agree with the conclu-
sion of Hoving [27], that volar synovitis is more easily
depicted and quantified in small hand joints than the
dorsal one, probably due to the flexor tendon position
towards the joint- more distant from the joint compara-
tive with extensor tendon, due to the presence of volar
plate (images of synovitis in MCP3 in both dorsal and
volar aspects in Figures 4,5). The position of the hand
and transducer for volar synovitis depicting is repre-
sented in Figure 6.
Conclusion
Volar US examination of the hand depicts more synovi-
tis in joints affected by RA and more PDUS was found
on that aspect of joints- it should be used in clinical
evaluation and also in clinical trials in addition to the
Table 5 Correlations between ESs, no of EPJ and other measures of disease activity
das28 VAS MD ES VOLAR ES DOR ES EPJ VOLAR EPJ DORSAL EPJ
das28 Pearson Corr. 1 ,342* ,394** ,374* ,345* ,390* ,373* ,341*
Sig. (2-tailed) ,027 ,010 ,015 ,025 ,011 ,015 ,027
VAS MD Pearson Corr. ,342* 1 ,245 ,289 ,146 ,293 ,265 ,278
Sig. (2-tailed) ,027 ,118 ,064 ,357 ,060 ,090 ,075
ES Pearson Corr. ,394** ,245 1 ,929** ,897** ,935** ,868** ,848**
Sig. (2-tailed) ,010 ,118 ,000 ,000 ,000 ,000 ,000
VOLAR ES Pearson Corr. ,374* ,289 ,929** 1 ,670** ,851** ,917** ,653**
Sig. (2-tailed) ,015 ,064 ,000 ,000 ,000 ,000 ,000
DOR ES Pearson Corr. ,345* ,146 ,897** ,670** 1 ,859** ,647** ,923**
Sig. (2-tailed) ,025 ,357 ,000 ,000 ,000 ,000 ,000
EPJ Pearson Corr. ,390* ,293 ,935** ,851** ,859** 1 ,904** ,921**
Sig. (2-tailed) ,011 ,060 ,000 ,000 ,000 ,000 ,000
VOLAR EPJ Pearson Corr. ,373* ,265 ,868** ,917** ,647** ,904** 1 ,672**
Sig. (2-tailed) ,015 ,090 ,000 ,000 ,000 ,000 ,000
DORSAL EPJ Pearson Corr. ,341* ,278 ,848** ,653** ,923** ,921** ,672** 1
Sig. (2-tailed) ,027 ,075 ,000 ,000 ,000 ,000 ,000
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Page 7 of 9dorsal one, as it was also correlated with all signs of RA
activity previously accepted. Scoring both dorsal and
volar synovitis could be the best sonographer’s option to
reflect disease activity in RA. However, the new scores
need to be verified regarding their sensitivity to change.
Further studies on the volar area- which allows an easier
visualization and grading of synovitis for MCPs and PIPs
and, though, could prove higher interobserver agree-
ment (repeatability) than the dorsal one in clinical prac-
tice and clinical trials- are warranted.
Ethics approval
This study was approved by the medical ethical commit-
tee of the “Carol Davila” University of Medicine and
Pharmacy Bucharest, Romania.
Acknowledgements
This study was supported by a grant from Romanian Ministry of Education,
Research, Youth and Sport, UEFISCSU, CNCSIS, Romania, competition “Idei-
PCE” - 2008, code ID 463
Authors’ contributions
All authors were involved in drafting this article and they all approved its
final version for publication. Study design and concept: VV, DP, RI, FB
Literature research: AB, VB, CC US examinations: VV Clinical examinations: SL
Acquisition of data: AB, VB, CC, MA Statistical analysis: FB Analysis and
interpretation of the data: FB, VV, RI.
Competing interests
The authors declare that they have no competing interests.
Received: 28 September 2010 Accepted: 3 June 2011
Published: 3 June 2011
References
1. Naredo E, Bonila G, Gamero F, Uson J, Carmona L, Laffon A: Assessment of
inflammatory activity in rheumatoid arthritis: a comparative study of
clinical evaluation and power Doppler ultrasonography. AnnRheumDis
2005, 64:375-81.
2. Grassi W, Cervini C: Ultrasonography in rheumatology; an evolving
technique. AnnRheumDis 1998, 57:268-70.
3. Wakefield RJ, Balint PV, Szudlarek M, Fillipucci E, Backhaus M,
d’Agostino MA, Naredo E, Iagnocco A, Schmidt WA, Bruyn G, Kane D,
o’Connor P, manger B, Joshua F, Koski J, Grassi W, Lassere M, Swen N,
Keinberger F, Klauser A, Ostergaard M, Brown AK, Machold K, Conaghan P:
Musculoskeletal ultrasound including definitions for musculoskeletal
pathology. J Rheumatol 2005, 32:2485-7.
4. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA,
Wakefield RJ, Manger B: Guidelines for musculoskeletal ultrasound in
rheumatology. AnnRheumDis 2001, 60:641-649.
5. Naredo E, Moller I, Moragues C, de Agustin JJ, Scheel AK, Grassi W, de
Miguel E, Backhaus M, Balint P, Bruyn G, de Agostino MA, Fillipucci E,
Kane D, Iagnocco A, Koski JM, Majordomo L, Schmidt WA, Swen WA,
Szudlarek M, Terslev L, Torp-Pedersen S, Uson J, Wakefield RJ, Werner C:
EULAR working Group for Musculoskeletal Ultrasound, Interobserver
reliability in musculoskeletal ultrasonography: results from a “Teach the
Teachers” rheumatologist course. AnnRheumDis 2006, 65:14-19.
6. Szudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS,
Ostergaard M: Interobserver agreement in ultrasonography of the finger
and toe joints in rheumatoid arthritis. ArthritisRheum 2003, 48:955-62.
7. Weidekamm C, Koller M, Weber M, Keinberger F: Diagnostic value of high
resolution B mode and Doppler sonography for imaging of hand and
finger joints in rheumatoid arthritis. ArthritisRheum 2003, 48:325-33.
8. D’Agostino MA, Conaghan P, Naredo E, Aegerter F, iagnocco A, Freestone J,
Fillipucci E, Moller I, Pineda C, Joshua F, Backhaus M, Keen H, Kaeley G,
Zisweiler HR, Schmidt WA, Balint P, Bruyn G, Jousse-Joulin S, Kane D,
Szudlarek M, Terslev L, Wakefield J: The OMERACT Ultrasound task force-
Advances and Priorities. J Rheumatol 2009, 36:1829-32.
9. Ellegard K, Torp-Pedersen S, Terslev L, Danneskiold-Samsoe B, Henriksen M,
Bliddal H: Ultrasound Colour Doppler measurements in a single joint as
measure of disease activity in patients with rheumatoid arthritis-
assessment of current validity. Rheumatology 2009, 48:254-257.
10. Scheel AK, Hermann KG, Kahler E, Pasewaldt D, Fritz J, Hamm B, Brunner E,
Muller G, Burmester GR, Backhaus M: A novel ultrasonographic synovitis
scoring system suitable for annalysing finger joint inflammation in
rheumatoid arthritis. Arthritis Rheum 2005, 52:733-743.
11. Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W,
Sattler H, Albrecht K, Kauffmann J, Beckner K, Sorensen H, Meier L,
Burmester GR, Schmidt WA: Evaluation of a novel 7 joint ultrasound score
Figure 5 Volar synovitis - MCP 3 joint.
Figure 4 Dorsal synovitis - MCP 3 joint.
Figure 6 Transducer position for volar synovitis depicting.
Vlad et al. BMC Musculoskeletal Disorders 2011, 12:124
http://www.biomedcentral.com/1471-2474/12/124
Page 8 of 9in daily rheumatologic practice; a pilot project. ArthritisRheum 2009,
61:1194-1201.
12. Naredo E, Gamero F, Bonilla G, Uson J, Carmona L, Laffon A:
Ultrasonographic assessment of inflammatory activity In rheumatoid
arthritis: comparison of extended versus reduced joint evaluation. Clin
Exp Rheumatol 2005, 23:881-4.
13. Loeuille D, Sommier JP: ScUSI, an ultrasound inflammatory score, predicts
Sharp’s progression at 7 months in RA patients. ArthritisRheum 2006,
54(Suppl):S139.
14. Vlad V, Constantinescu C, Berghea F, Predeteanu D, Ionescu R: Clinical
examination of hand joints in RA is better correlated with volar US
examination. AnnRheumDis 2006, 65(SII).
15. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS,
Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism
association 1987 revised criteria for the classification of Rheumatoid
Arthritis. Arthritis and Rheumatism 1988, 31:315-324.
16. Smolen JS, Braedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van
Riel PL, Tugwell P: A simplified Disease activity index for rheumatoid
arthritis for use in clinical practice. Rheumatology(Oxford) 2003, 42:244-257.
17. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS:
Acute phase reactants add little to disease activity indices for
rheumatoid arthritis- validation of a clinical activity score. Arthritis res
Ther 2005, 7:796-806.
18. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuven MA, van Gestel AM, van
Riel PL, et al: Modified disease activity score that includes twenty eight
joint counts. Development and validation in a prospective longitudinal
study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-8.
19. Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Bonnet V, Beckers C,
Malaise MG: Rheumatoid hand joint synovitis: gray scale and Power
Doppler US quantifications following anti-TNF alfa treatment-pilot study.
Radiology 2003, 229:562-569.
20. Naredo E, Rodriguez M, Campos C, Rodriguex-Heredia JM, Medina J,
Giner E, Martinez O, Toyos J, Ruiz T, Ros I, Tuneu R, Corominas H,
Moragues C, Minguez D, Willisch A, Gonzalez-Cruz I, Aragon A, Iglesias G,
Salvador G, Puigdollers A, Galinez E, Garrido N, Salaberri J, Raya E, Salles M,
Diaz C, Cuadra JL, Garrido J: Validity, Reproducibility and Responsiveness
of a Twelve-Joint Simplified Power Doppler Ultrasonographic
Assessment of Joint Inflammation in Rheumatoid Arthritis. ArthritisRheum
2008, 59:515-522.
21. Backhaus M, Kamradt T, Sandrock D, Loreck D, fritz J, Wolf KJ, Raber H,
Hamm B, Burmester GR, Bollow M: Arthritis of the finger joints: a
comprehensive approach comparing conventional radiography,
scintigraphy, ultrasound, and contrast- enhanced magnetic resonance
imaging. ArthritisRheum 1999, 42:1232-54.
22. Dougados M, Jousse Jolin S, Mistretta F, d’Agostino MA, Backhaus M,
Bentin J, Chales G, Chary-Valkenaere I, Conaghan P, Etcepare F, Gaudin P,
Grassi W, van der Hajde D, Sellam J, Naredo E, Szudlarek M, wakefield R,
Saraux A: Evaluation of several ultrasonography scoring systems of
synovitis and comparison to clinical examination: Results from a
prospective multicenter study of Rheumatoid Arthritis. Ann Rheum Dis
2010, 69:828-33.
23. Ellegaard K, Torp-Pedersen S, Terslev L, Danneskiold-Samsøe B, Henriksen M,
Bliddal H: Ultrasound colour Doppler measurements in a single joint as
measure of disease activity in patients with rheumatoid arthritis-
assessment of concurrent validity. Rheumatology 2009, 48:254-257.
24. Iagnocco A, Filippucci E, Perella C, Ceccarelli F, Cassara E, Allessandri C,
Sabatini E, Grassi W, Valesini G: Clinical and Ultrasonographic Monotoring
of response to Adalimumab treatment in Rheumatoid Arthritis. J
Rheumatol 2008, 35:35-40.
25. Smolen JS, Aletaha D, Biljsma WJ, Brredveld FC, Boumpas D, Burmester GR,
Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofski A, Gomez-
Reino JJ, Haraoui B, Kalden J, Keystone E, Kvien T, McInnes I, montecucco C,
schoels M, van der Heijde D: Treating rheumatoid arthritis to target:
recommendations of an international task force. AnnRheumDis 2010,
69:631-637.
26. Joshua F, Lasserre M, Bruyn G, Szudlarek M, Naredo E, Schmidt WA, Balint P,
Fillipucci E, Backhaus M, Iagnocco A, Scheel A, Kane D, Grassi W,
Conaghan P, Wakefield RJ, D’Agostino MA: Summary findings of a
systematic review of the ultrasound assessment of synovitis. J Rheumatol
2007, 34:839-47.
27. Hoving JL, Buchbinder R, Hall S, Lawler G, Coombs P, McNealy S, Bird P,
Connell D: A comparison of Magnetic Resonance Imaging, Sonography
and radiography of the hand in patients with Early Rheumatoid Arthritis.
J Rheumatol 2004, 31:663-75.
28. Ostergaard M, Szudlarek M: Ultrasonography: a valid method for
assessing rheumatoid arthritis. Arthritis Rheum 2005, 52:681-686.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/12/124/prepub
doi:10.1186/1471-2474-12-124
Cite this article as: Vlad et al.: Ultrasound in rheumatoid arthritis - volar
versus dorsal synovitis evaluation and scoring. BMC Musculoskeletal
Disorders 2011 12:124.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vlad et al. BMC Musculoskeletal Disorders 2011, 12:124
http://www.biomedcentral.com/1471-2474/12/124
Page 9 of 9